
Sign up to save your podcasts
Or
Send us a text
Nick Jikomes talks to Dr. Nathan Price, who has a Ph.D. in bioengineering and has been faculty at the University of Washington and the Institute of Systems Biology. He was also CEO of a health intelligence startup called Onegevity, which recently merged with Thorne HealthTech, where he is the Chief Science Officer.
Nathan and Nick discussed various topics in personalized medicine, digital phenotyping, and systems biology, including metabolism and blood sugar monitoring, the microbiome and diet, aging and longevity, and more. They discussed the basic biology of these things as well as different emerging technologies related to health monitoring.
*Not medical advice.
Support the show
All episodes, show notes, transcripts, and more at the M&M Substack
Affiliates:
For all the ways you can support my efforts
4.8
7171 ratings
Send us a text
Nick Jikomes talks to Dr. Nathan Price, who has a Ph.D. in bioengineering and has been faculty at the University of Washington and the Institute of Systems Biology. He was also CEO of a health intelligence startup called Onegevity, which recently merged with Thorne HealthTech, where he is the Chief Science Officer.
Nathan and Nick discussed various topics in personalized medicine, digital phenotyping, and systems biology, including metabolism and blood sugar monitoring, the microbiome and diet, aging and longevity, and more. They discussed the basic biology of these things as well as different emerging technologies related to health monitoring.
*Not medical advice.
Support the show
All episodes, show notes, transcripts, and more at the M&M Substack
Affiliates:
For all the ways you can support my efforts
7,150 Listeners
5,301 Listeners
1,570 Listeners
654 Listeners
565 Listeners
419 Listeners
2,616 Listeners
7,904 Listeners
28,321 Listeners
189 Listeners
138 Listeners
459 Listeners
80 Listeners
64 Listeners
99 Listeners